• Something wrong with this record ?

Receptor subtype abundance as a tool for effective intracellular signalling

J Myslivecek, M Novakova, M Klein

. 2008 ; 8 (1) : 66-79.

Language English Country Netherlands

Document type Review

The regulation of heart function is one of the essentials for the survival of organism. Therefore, the effective mechanisms of regulation can minimize the energy requirements and improve the ability to react to different needs on time and appropriately. Two receptor types, beta-adrenoceptors and muscarinic receptors, with almost antagonistic function, are "basic regulators" of the heart parameters. It is relevant to mention that beside the main adrenoceptors and muscarinic receptors subtypes (beta(1)- and M(2)-subtype), other minor subtypes that regulate heart function, i.e. beta-, beta-adrenoceptors, alpha(1)-adrenoceptors and minor subtypes of muscarinic receptors (M(1), M(3) and M(5)) are present in the heart. In this regard is intriguing that just two catecholamines (adrenaline, noradrenaline) have many "targets"--receptors that differ so much in the functional consequences of their activation: while beta(1)- and beta(2)-adrenoceptors cause cardiostimulation, beta(3)-adrenoceptors are responsible for cardioinhibition and alpha(1)-adrenoceptors contribute to enhanced inotropy. Similarly, some data show that other muscarinic receptors than M(2) muscarinic subtype, are expressed in the heart and these minor subtype(s) can contribute to the heart regulation in similar way as beta(3)-adrenoceptors to the catecholamine action. Taken together, regulation of heart function through different receptor subtypes and using homologous and heterologous regulation can represent an effective tool for coping with permanently changing environmental conditions.

000      
02953naa 2200325 a 4500
001      
bmc10034976
003      
CZ-PrNML
005      
20111210200444.0
008      
101221s2008 ne e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Mysliveček, Jaromír, $d 1968- $7 nlk19990073583
245    10
$a Receptor subtype abundance as a tool for effective intracellular signalling / $c J Myslivecek, M Novakova, M Klein
314    __
$a Institute of Physiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. jmys@lf1.cuni.cz
520    9_
$a The regulation of heart function is one of the essentials for the survival of organism. Therefore, the effective mechanisms of regulation can minimize the energy requirements and improve the ability to react to different needs on time and appropriately. Two receptor types, beta-adrenoceptors and muscarinic receptors, with almost antagonistic function, are "basic regulators" of the heart parameters. It is relevant to mention that beside the main adrenoceptors and muscarinic receptors subtypes (beta(1)- and M(2)-subtype), other minor subtypes that regulate heart function, i.e. beta-, beta-adrenoceptors, alpha(1)-adrenoceptors and minor subtypes of muscarinic receptors (M(1), M(3) and M(5)) are present in the heart. In this regard is intriguing that just two catecholamines (adrenaline, noradrenaline) have many "targets"--receptors that differ so much in the functional consequences of their activation: while beta(1)- and beta(2)-adrenoceptors cause cardiostimulation, beta(3)-adrenoceptors are responsible for cardioinhibition and alpha(1)-adrenoceptors contribute to enhanced inotropy. Similarly, some data show that other muscarinic receptors than M(2) muscarinic subtype, are expressed in the heart and these minor subtype(s) can contribute to the heart regulation in similar way as beta(3)-adrenoceptors to the catecholamine action. Taken together, regulation of heart function through different receptor subtypes and using homologous and heterologous regulation can represent an effective tool for coping with permanently changing environmental conditions.
650    _2
$a zvířata $7 D000818
650    _2
$a srdce $x fyziologie $7 D006321
650    _2
$a lidé $7 D006801
650    _2
$a biologické modely $7 D008954
650    _2
$a beta-adrenergní receptory $x fyziologie $7 D011943
650    _2
$a receptory spřažené s G-proteiny $x fyziologie $7 D043562
650    _2
$a receptory muskarinové $x fyziologie $7 D011976
650    _2
$a signální transdukce $x fyziologie $7 D015398
650    _2
$a financování organizované $7 D005381
655    _2
$a přehledy $7 D016454
700    1_
$a Nováková, Martina. $7 _AN029770
700    1_
$a Klein, Martin $7 xx0092749
773    0_
$w MED00173187 $t Cardiovascular & hematological disorders drug targets $g Roč. 8, č. 1 (2008), s. 66-79 $x 1871-529X
910    __
$a ABA008 $b x $y 7
990    __
$a 20110223132700 $b ABA008
991    __
$a 20110414150241 $b ABA008
999    __
$a ok $b bmc $g 823413 $s 688840
BAS    __
$a 3
BMC    __
$a 2008 $b 8 $c 1 $d 66-79 $i 1871-529X $m Cardiovascular & hematological disorders drug targets $n Cardiovasc Hematol Disord Drug Targets $x MED00173187
LZP    __
$a 2011-2B/ewme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...